Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
N Engl J Med. 2022 Mar 3;386(9):892-894. doi: 10.1056/NEJMc2112186.
N Engl J Med. 2022.
PMID: 35235733
Clinical Trial.
No abstract available.